Patents by Inventor Georg Lauer

Georg Lauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Epitopes of hepatitis C virus
    Publication number: 20080044433
    Abstract: The invention provides compositions containing HCV epitopes, which are recognized by cytotoxic T lymphocytes. Such polypeptides are used in prophylactic vaccines, immunotherapies, and assays to monitor the progress or success of immune interventions. The compositions are optimized to elicit an immune response in a genetically-diverse population of individuals.
    Type: Application
    Filed: April 10, 2007
    Publication date: February 21, 2008
    Inventors: Georg Lauer, Kei Ouchi, Bruce Walker
  • Soluble virus-specific T-cell receptor compositions
    Publication number: 20080015139
    Abstract: Compositions and methods for diagnosing a viral infection and methods of inhibiting such an infection are described. The methods are based on the identification of T-cell receptor gene sequences from cytotoxic T cell clones that are specific for HIV-1 or HCV. Soluble T-cell receptor compositions that bind to HLA class I-restricted of HIV and HCV pathogens were identified and constructed.
    Type: Application
    Filed: April 5, 2007
    Publication date: January 17, 2008
    Inventors: Mathias Lichterfeld, Xu Yu, Bruce Walker, Marcus Altfeld, Georg Lauer
  • Epitopes of hepatitis C virus
    Patent number: 7201904
    Abstract: The invention provides compositions containing HCV epitopes, which are recognized by cytotoxic T lymphocytes. Such polypeptides are used in prophylactic vaccines, immunotherapies, and assays to monitor the progress or success of immune interventions. The compositions are optimized to elicit an immune response in a genetically-diverse population of individuals.
    Type: Grant
    Filed: May 16, 2003
    Date of Patent: April 10, 2007
    Assignee: The General Hospital Corporation
    Inventors: Georg Lauer, Kei Ouchi, Bruce D. Walker
  • Epitopes of hepatitis C virus
    Publication number: 20040105868
    Abstract: The invention provides compositions containing HCV epitopes, which are recognized by cytotoxic T lymphocytes. Such polypeptides are used in prophylactic vaccines, immunotherapies, and assays to monitor the progress or success of immune interventions. The compositions are optimized to elicit an immune response in a genetically-diverse population of individuals.
    Type: Application
    Filed: May 16, 2003
    Publication date: June 3, 2004
    Inventors: Georg Lauer, Kei Ouchi, Bruce D. Walker